News
The National Nuclear Security Administration will complete the First Production Unit of the B61-13 this fiscal year, according to Fox News April 9. With ...
During a live event, Martin Voss, MD, reviewed the trials of lenvatinib plus pembrolizumab, cabozantinib plus nivolumab, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback